BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qi X, Feng J, Shao X, Xu Y, Li H, Guo X. Portal Hypertension in a Patient With Recurrent Pancreatic Cancer After Radiotherapy and Systemic Chemotherapy. J Clin Exp Hepatol 2018;8:106-8. [PMID: 29743803 DOI: 10.1016/j.jceh.2017.11.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Yan X, Hui Y, Hua Y, Huang L, Wang L, Peng F, Tang C, Liu D, Song J, Wang F. EG-VEGF silencing inhibits cell proliferation and promotes cell apoptosis in pancreatic carcinoma via PI3K/AKT/mTOR signaling pathway. Biomed Pharmacother 2019;109:762-9. [PMID: 30551529 DOI: 10.1016/j.biopha.2018.10.125] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
2 Zheng K, Guo X, Feng J, Bai Z, Shao X, Yi F, Zhang Y, Zhang R, Liu H, Romeiro FG, Qi X. Gastrointestinal Bleeding due to Pancreatic Disease-Related Portal Hypertension. Gastroenterol Res Pract 2020;2020:3825186. [PMID: 32308674 DOI: 10.1155/2020/3825186] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Lee KG, Roy V, Laszlo M, Atkins KM, Lin KJ, Tomassian S, Hendifar AE. Symptom Management in Pancreatic Cancer. Curr Treat Options Oncol 2021;22:8. [PMID: 33387071 DOI: 10.1007/s11864-020-00801-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]